Neural Therapeutics Inc. (CSE:NURL)

Market Cap	4.22M
Revenue (ttm)	n/a
Net Income (ttm)	-1.03M
Shares Out	168.70M
EPS (ttm)	-0.01
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	3,002
Average Volume	272,964
Open	0.0200
Previous Close	0.0150
Day's Range	0.0200 - 0.0200
52-Week Range	0.0100 - 0.0500
Beta	n/a
RSI	48.14
Earnings Date	Nov 21, 2025

About Neural Therapeutics

Neural Therapeutics Inc., an ethnobotanical drug discovery and development company, develops over-the-counter dietary supplements and psychedelic-based therapeutic drugs to treat mental illnesses in Canada. The company utilizes psychoactive plants, such as San Pedro, a cactus containing mescaline, for the creation of plant-based traditional medicine. Its products target substance use disorders, including alcohol and opioid dependence. The company was formerly known as Psychedelic Science Corp. and changed its name to Neural Therapeutics Inc. in...

• Industry: Biological Products, Except Diagnostic Substances
• Founded: 2020
• Country: Canada
• Stock Exchange: Canadian Securities Exchange
• Ticker Symbol: NURL